CT 327 in the Treatment of Psoriasis Vulgaris

Summary

This study will look at how safe and effective, a novel agent, CT 327 cream is in treating patients with mild to moderate psoriasis vulgaris (PV). Patients will be treated twice daily for 8 weeks on specific lesions of PV and safety and symptoms of PV will be assessed throughout the treatment period.

Timeline

Start

2010-03

Primary completion

2011-01

Completion

2011-01

Drugs

Indications